These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24822054)
21. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach. Kashyap M; Jaiswal V; Farooq U Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876 [TBL] [Abstract][Full Text] [Related]
22. Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Colmenares M; Kima PE; Samoff E; Soong L; McMahon-Pratt D Infect Immun; 2003 Jun; 71(6):3172-82. PubMed ID: 12761096 [TBL] [Abstract][Full Text] [Related]
24. Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis. Ramirez L; Corvo L; Duarte MC; Chávez-Fumagalli MA; Valadares DG; Santos DM; de Oliveira CI; Escutia MR; Alonso C; Bonay P; Tavares CA; Coelho EA; Soto M Parasit Vectors; 2014 Jan; 7():3. PubMed ID: 24382098 [TBL] [Abstract][Full Text] [Related]
25. 3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine. Wang Q; Barry MA; Seid CA; Hudspeth EM; McAtee CP; Heffernan MJ J Biomed Mater Res B Appl Biomater; 2018 May; 106(4):1587-1594. PubMed ID: 28804955 [TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. Chamakh-Ayari R; Bras-Gonçalves R; Bahi-Jaber N; Petitdidier E; Markikou-Ouni W; Aoun K; Moreno J; Carrillo E; Salotra P; Kaushal H; Negi NS; Arevalo J; Falconi-Agapito F; Privat A; Cruz M; Pagniez J; Papierok GM; Rhouma FB; Torres P; Lemesre JL; Chenik M; Meddeb-Garnaoui A PLoS One; 2014; 9(5):e92708. PubMed ID: 24786587 [TBL] [Abstract][Full Text] [Related]
36. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani. Guha R; Das S; Ghosh J; Naskar K; Mandala A; Sundar S; Dujardin JC; Roy S Vaccine; 2013 Apr; 31(15):1905-15. PubMed ID: 23499564 [TBL] [Abstract][Full Text] [Related]
37. Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection. Costa LE; Chávez-Fumagalli MA; Martins VT; Duarte MC; Lage DP; Lima MI; Pereira NC; Soto M; Tavares CA; Goulart LR; Coelho EA Parasitology; 2015 Sep; 142(10):1335-47. PubMed ID: 26099574 [TBL] [Abstract][Full Text] [Related]
38. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Wanasen N; Xin L; Soong L Int J Parasitol; 2008 Mar; 38(3-4):417-29. PubMed ID: 17959178 [TBL] [Abstract][Full Text] [Related]